Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Comparative Evaluation of Intraligamentary Injection of Dexamethasone, Diclofenac Sodium, and Chymotrypsin for Enhancing the Success of 4% Articaine Buccal Infiltration in Mandibular Molars With Symptomatic Irreversible Pulpitis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing intraligamentary injections of dexamethasone, diclofenac sodium, and chymotrypsin to improve the success of 4% articaine buccal infilt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Articaine (articaine)
  • Chymotrypsin (chymotrypsin)
  • DEXAMETHASONE (Dexamethasone)
  • DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

Sponsor: Fayoum University | Conditions: Irreversible Pulpitis (Toothache) | Phase 4 | Status: COMPLETED